Vivactil versus Surmontil, both tricyclic antidepressants popularly prescribed for anxiety disorders, exhibit distinct pharmacological profiles. Vivactil (nortriptyline), known for its potent inhibitory effects on serotonin and norepinephrine reuptake, demonstrates a higher affinity for alpha-2 adrenergic receptors. This influences its potential fo